State Street Corp Acquires 5% Stake in Telix Pharmaceuticals
Company Announcements

State Street Corp Acquires 5% Stake in Telix Pharmaceuticals

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

State Street Corporation has emerged as a substantial holder in Telix Pharmaceuticals Limited, holding a 5.12% stake with 17,126,445 votes as of 24th July 2024. The details of the voting power, relevant interests, and considerations for the shares acquired were formalized in a notice filed on 26th July 2024.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Proposes New Security Issue
TipRanks Australian Auto-Generated NewsdeskTelix Pharmaceuticals Secures A$650M in Bonds
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!